ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Rapid generation of a mouse model for Middle East respiratory syndrome

Zhao, Jincun; Li, Kun; Wohlford-Lenane, Christine; Agnihothram, Sudhakar S.; Fett, Craig; Zhao, Jingxian; Gale, Michael J., Jr.; Baric, Ralph S.; Enjuanes, Luis; Gallagher, Tom; McCray, Paul B., Jr.; Perlman, Stanley*
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA2014-4-1DOI: 10.1073/pnas.1323279111
352被引10阅读
引用收藏
分享

摘要

In this era of continued emergence of zoonotic virus infections, the rapid development of rodent models represents a critical barrier to public health preparedness, including the testing of antivirus therapy and vaccines. The Middle East respiratory syndrome coronavirus (MERS-CoV) was recently identified as the causative agent of a severe pneumonia. Given the ability of coronavirus to rapidly adapt to new hosts, a major public health concern is that MERS-CoV will further adapt to replication in humans, triggering a pandemic. No small-animal model for this infection is currently available, but studies suggest that virus entry factors can confer virus susceptibility. Here, we show that mice were sensitized to MERS-CoV infection by prior transduction with adenoviral vectors expressing the human host-cell receptor dipeptidyl peptidase 4. Mice developed a pneumonia characterized by extensive inflammatory-cell infiltration with virus clearance occurring 6-8 d after infection. Clinical disease and histopathological changes were more severe in the absence of type-I IFN signaling whereas the T-cell response was required for virus clearance. Using these mice, we demonstrated the efficacy of a therapeutic intervention (poly I:C) and a potential vaccine [Venezuelan equine encephalitis replicon particles expressing MERS-CoV spike protein]. We also found little protective cross-reactivity between MERS-CoV and the severe acute respiratory syndrome-CoV. Our results demonstrate that this system will be useful for MERS-CoV studies and for the rapid development of relevant animal models for emerging respiratory viral infections.

学科与关键词

关键词
emerging pathogeninterferonSARS
相关
加载中…
  • Middle East Respiratory Syndrome Coronavirus Causes Multiple Organ Damage and Lethal Disease in Mice Transgenic for Human Dipeptidyl Peptidase 4
    Li, Kun; Wohlford-Lenane, Christine; Perlman, Stanley; Zhao, Jincun; Jewell, Alexander K.; Reznikov, Leah R.; Gibson-Corley, Katherine N.; Meyerholz, David K.; McCray, Paul B., Jr.*JOURNAL OF INFECTIOUS DISEASES, 2016, 213(5): 712-722.被引 307
  • Current understanding of middle east respiratory syndrome coronavirus infection in human and animal models
    Wang, Yanqun; Sun, Jing; Zhu, Airu; Zhao, Jingxian; Zhao, Jincun*Journal of Thoracic Disease, 2018, 10: S2260-S2271.被引 19
  • Receptor Variation and Susceptibility to Middle East Respiratory Syndrome Coronavirus Infection
    Barlan, Arlene; Zhao, Jincun; Sarkar, Mayukh K.; Li, Kun; McCray, Paul B., Jr.; Perlman, Stanley; Gallagher, Tom*Journal of Virology, 2014, 88(9): 4953-4961.被引 87
查看全部 →

发表信息

论文状态
公开发表
期刊
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
发表日期
2014-04-01
卷期
第 111 卷, 第 13 期
页码
4970-4975
DOI
10.1073/pnas.1323279111
语言
ENGLISH
期刊收录
SCIE
期刊等级
Q1
成果收录
SCIE
资助标注
National Institutes of Health [RO1AI091322, PO106099, AI074973, AI083019, AI057157]

作者

  • Z

    Zhao, Jincun (第一作者)

  • L

    Li, Kun

查看全部 12 位作者收起作者
  • W

    Wohlford-Lenane, Christine

  • A

    Agnihothram, Sudhakar S.

  • F

    Fett, Craig

  • Z

    Zhao, Jingxian

  • G

    Gale, Michael J., Jr.

  • B

    Baric, Ralph S.

  • E

    Enjuanes, Luis

  • G

    Gallagher, Tom

  • M

    McCray, Paul B., Jr.

  • P

    Perlman, Stanley (通讯)

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417